Tumpa, a 14 year old high school student, was diagnosed with TB on March 27, 2011. Although she started taking TB medication the day after, she experienced treatment failure after three months of treatment and was diagnosed with Multi Drug Resistance Tuberculosis (MDR-TB). With her new diagnosis, Tumpa started to take her medication for MDR-TB in August of that year. However, after completing 16 months of treatment, her sputum culture and follow up result remained positive. She was then diagnosed with extensively drug-resistant TB (XDR-TB) in November 2012.
DOTS represents the best strategy for coordinating TB services within the broader health system, mobilizing wide support at the operational level, reducing TB incidence, and preventing further drug resistance.
Programmatic Management of Drug-resistant TB (PMDT): While the causes of multi-drug resistant TB are similar in all high burden countries (low adherence, weak DOTS, poor treatment compliance, inadequate drug supplies, direct transmission, etc.).
TB / HIV
TB CARE II works to link HIV and TB advocacy and to promote a unified response, and works with National TB and HIV/AIDS Programs to integrate planning and service delivery mechanisms to effectively tackle the dual epidemics.
Health Systems Strengthening
TB CARE II supports health systems improvement through our country programs, emphasizing management capacity building, integration, and results-oriented process improvement.
|https://www.youtube.com/watch?v=fqw6BpSIBJ0 read more|